Home Cart Sign in  
Chemical Structure| 141400-58-0 Chemical Structure| 141400-58-0

Structure of PX-12
CAS No.: 141400-58-0

Chemical Structure| 141400-58-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PX-12 is an irreversible thioredoxin-1 (Trx-1) inhibitor with antitumor activity.

Synonyms: IV-2; DB05448; 1-methyl propyl 2-imidazolyl disulfide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PX-12

CAS No. :141400-58-0
Formula : C7H12N2S2
M.W : 188.31
SMILES Code : CCC(SSC1=NC=CN1)C
Synonyms :
IV-2; DB05448; 1-methyl propyl 2-imidazolyl disulfide
MDL No. :MFCD18086851
InChI Key :BPBPYQWMFCTCNG-UHFFFAOYSA-N
Pubchem ID :219104

Safety of PX-12

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Thioredoxin

In Vitro:

Cell Line
Concentration Treated Time Description References
intestinal epithelial cells 1 μM 12 hours To explore the inhibitory effect of PX-12 on TRX1, the results showed that PX-12 reversed the inhibitory effect of Nano AC on the NLRP3/Caspase-11/GSDMD signaling pathway PMC11699839
HCT-15 20 μM 16 h PX-12 reversed the upregulation of phosphorylated NF-κB, CAT, and SOD2 protein levels in HCT-15 cells and reversed ALDH1L2-mediated CRC radioresistance. PMC9381770
HCT 116 20 μM 16 h PX-12 reversed the upregulation of phosphorylated NF-κB, CAT, and SOD2 protein levels in HCT 116 cells and reversed ALDH1L2-mediated CRC radioresistance. PMC9381770
human neutrophils 10 μM or 100 μM 16 hours PX-12 inhibited thioredoxin function, increasing the sensitivity of fungal hyphae to both H2O2- and neutrophil-mediated killing. PMC3534057
human aortic endothelial cells (HAECs) 1 µM 2 hours inhibiting TRX completely blunted the protective effect of silencing TXNIP PMC9243351
HT-29 cells 5 µM 24 hours To investigate the effect of PX-12 on IL-6-induced nuclear translocation of Trx-1 and pSTAT3. Results showed that PX-12 treatment decreased nuclear expression of Trx-1 and pSTAT3 in HT-29 cells. PMC10526669
LNCaP SB5 0.5 μM, 1.5 μM, 2.5 μM 72 hours To evaluate the effect of PX-12 on the viability of CRPC cells, the results showed that PX-12 significantly reduced the viability of CRPC cells, and was more sensitive under CSS conditions. PMC5663934
LNAI 0.5 μM, 1.5 μM, 2.5 μM 72 hours To evaluate the effect of PX-12 on the viability of CRPC cells, the results showed that PX-12 significantly reduced the viability of CRPC cells, and was more sensitive under CSS conditions. PMC5663934
22Rv1 0.5 μM, 1.5 μM, 2.5 μM 72 hours To evaluate the effect of PX-12 on the viability of CRPC cells, the results showed that PX-12 significantly reduced the viability of CRPC cells, and was more sensitive under CSS conditions. PMC5663934
C4-2b 0.5 μM, 1.5 μM, 2.5 μM 72 hours To evaluate the effect of PX-12 on the viability of CRPC cells, the results showed that PX-12 significantly reduced the viability of CRPC cells, and was more sensitive under CSS conditions. PMC5663934

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice fungal keratitis model topical application 3 mM twice, 6 hours apart PX-12 significantly enhanced neutrophil-mediated fungal killing and reduced fungal growth. PMC3534057
Nu/Nu mice Castration-resistant prostate cancer model Intraperitoneal injection 12.5 mg/kg 5 times a week, lasting several weeks To evaluate the effect of PX-12 on the growth of castration-resistant prostate cancer tumors, the results showed that PX-12 significantly inhibited tumor growth and led to complete tumor regression. PMC5663934
BALB/c Nude mice xenograft colorectal cancer model intraperitoneal injection 12 mg/kg daily until the end of the experiment PX-12 significantly inhibited tumor growth, and tumor weight decreased by ~90% following combined treatment with radiotherapy and PX-12, indicating its possible clinical application. PMC9381770
C57BL/6 mice AOM/DSS-induced colitis-associated cancer model Tail vein injection 12.5 mg/kg Daily administration during three recovery periods To investigate the effect of PX-12 on the AOM/DSS-induced colitis-associated cancer model. Results showed that PX-12 significantly reduced tumor formation and suppressed nuclear expression of Trx-1 and pSTAT3. PMC10526669

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00736372 Metastatic Cancer|Advanced Can... More >>cer Less << PHASE1 COMPLETED 2025-08-09 TGen Clinical Research Service... More >>s at Scottsdale Healthcare, Scottsdale, Arizona, 85258, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, 29605, United States|Tyler Cancer Center, Tyler, Texas, 75702, United States Less <<
NCT00417287 Pancreatic Neoplasms PHASE2 TERMINATED 2025-04-09 TGen Clinical Research Service... More >>s at Scottsdale Healthcare, Scottsdale, Arizona, 85258, United States|Arizona Cancer Center, University of Arizona, Tucson, Arizona, 85724, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.31mL

1.06mL

0.53mL

26.55mL

5.31mL

2.66mL

53.10mL

10.62mL

5.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories